Pediatric Cancer Recognition Training in Botswana

Jeremy S Slone1, Elise Ishigami2, Parth S Mehta1

  • 1Texas Children's Cancer and Hematology Centers, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA.

Insights

Training healthcare workers in Botswana improved recognition and referral of childhood cancers. This initiative in low- and middle-income countries (LMICs) addresses delayed presentation, a key barrier to improving pediatric cancer survival rates.

Area of Science:

  • Pediatric Oncology
  • Global Health
  • Healthcare Worker Training

Background:

  • Delayed presentation of childhood cancer significantly hinders survival rates in low- and middle-income countries (LMICs).
  • Botswana, with a population of 2 million, has a single pediatric cancer treatment center, Princess Marina Hospital (PMH).

Purpose of the Study:

  • To assess the impact of a pediatric cancer recognition training program on healthcare workers in Botswana.
  • To identify existing limitations in pediatric cancer knowledge and referral processes.

Main Methods:

  • A pediatric cancer recognition training program was implemented, reaching 50% of government hospitals in Botswana.
  • 362 healthcare workers were trained on recognizing and referring pediatric cancer cases to PMH.
  • Post-workshop evaluations were conducted to assess knowledge improvement.

Main Results:

  • The training program identified limitations in current pediatric cancer knowledge among healthcare workers.
  • Attendees showed significant improvement in understanding pediatric cancer signs and symptoms.
  • Knowledge of the referral process to PMH also improved post-training.

Conclusions:

  • Targeted training can enhance healthcare workers' ability to recognize and refer children with cancer in resource-limited settings.
  • Improving early detection and referral is crucial for improving pediatric cancer outcomes in LMICs.
  • The program demonstrated effectiveness in addressing knowledge gaps and improving the referral pathway.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.4K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K